Startseite Medizin The effect of therapy on plasma ghrelin and leptin levels, and appetite in children with iron deficiency anemia
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The effect of therapy on plasma ghrelin and leptin levels, and appetite in children with iron deficiency anemia

  • Nuran Kucuk , Zerrin Orbak EMAIL logo , Cahit Karakelloglu und Fatih Akcay
Veröffentlicht/Copyright: 23. Februar 2019

Abstract

Background

It is known that iron deficiency anemia effects appetite and growth negatively. The aim of this study was to investigate the effect of iron therapy on appetite, growth and plasma ghrelin and leptin levels in children aged between 12 and 24 months with isolated nutritional iron deficiency anemia.

Methods

Iron deficiency anemia was diagnosed by clinic and laboratory findings. All 19 cases were given 5 mg/kg/day iron therapy for 3 months.

Results

The mean plasma ghrelin level was 936.7±428.8 pg/mL before therapy and it increased to 1284.7±533.3 pg/mL (p<0.001) while the mean plasma leptin level decreased from 3.4±1.6 ng/mL to 1.9±1.0 ng/mL (p<0.01) after therapy. The amount of daily caloric intake, carbohydrate and protein intake were significantly increased after therapy (p<0.001). Δ body weight was correlated with plasma ghrelin levels before and after therapy significantly.

Conclusions

In conclusion, the findings of this study indicate that plasma ghrelin level increases and leptin level decreases and growth accelerates because of an increase in appetite and daily calories, carbohydrate and protein amount in children with nutritional iron deficiency anemia after iron therapy. The increase in appetite and acceleration on growth in iron deficiency anemia might result from decreased leptin and increased plasma ghrelin levels. The most important finding of this study is significantly increased plasma ghrelin levels after iron therapy, and this finding might be related to both the improved appetite and catch-up growth.


Corresponding author: Dr. Zerrin Orbak, MD, Faculty of Medicine, Department of Pediatric Endocrinology, Atatürk University, Erzurum 25240, Turkey, Phone: +009 05333559339

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  6. Conflict of interest: The authors declare that they have no conflict of interests regarding this article.

References

1. Paoletti G, Bogen DL, Ritchey AK. Severe iron-deficiency anemia still an issue in toddlers. Clin Pediatr (Phila) 2014;53:1352–8.10.1177/0009922814540990Suche in Google Scholar

2. Moehlecke M, Canani LH, Silva LO, Trindade MR, Friedman R, et al. Determinants of body weight regulation in humans. Arch Endocrinol Metab 2016;60:152–62.10.1590/2359-3997000000129Suche in Google Scholar

3. Frago LM, Chowen JA. Hypothalamic leptin and ghrelin signaling as targets for improvement in metabolic control. Curr Pharm Des 2015;21:3596–605.10.2174/1381612821666150710145428Suche in Google Scholar

4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656–60.10.1038/45230Suche in Google Scholar

5. Topaloglu AK, Hallioglu O, Canim A, Duzovali O, Yilgor E. Lack of association between plasma leptin levels and appetite in children with iron deficiency. Nutrition 2001;17:657–9.10.1016/S0899-9007(01)00570-6Suche in Google Scholar

6. Dossa RA, Ategbo EA, Van Raaij JM, de Graaf C, Hautvast JG. Multıvitamin-multimineral and iron supplementation did not improve appetite of young stunted and anemıc Beninese children. J Nutr 2001;131:2874–9.10.1093/jn/131.11.2874Suche in Google Scholar PubMed

7. Isguven P, Arslanoglu I, Erol M, Yildiz M, Adal E, et al. Serum levels of ghrelin, leptin, IGF-1, IGFBP-3, insulin, thyroid hormones and cortisol in prepubertal children with iron deficiency. Endocrine J 2007;54:985–90.10.1507/endocrj.K07-031Suche in Google Scholar PubMed

8. Lawless JW, Latham MC, Stephenson LS, Kinoti SN, Pertet AM. Iron supplementation improves appetite and growth in anemic Kenyan primary school children. J Nutr 1994:124:645–54.10.1093/jn/124.5.645Suche in Google Scholar PubMed

9. Neyzi O, Bundak R, Gokcay G, Gunoz H, Furman A, et al. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol 2015;7:280–93.10.4274/jcrpe.2183Suche in Google Scholar PubMed PubMed Central

10. Ozdemir N. Iron deficiency anemia from diagnosis to treatment in children. Turk Pediatri Ars 2015;50:11–9.10.5152/tpa.2015.2337Suche in Google Scholar PubMed PubMed Central

11. Kouno T, Akiyama N, Ito T, Fujieda K, Nanchi I, et al. The role of acylated-ghrelin in the regulation of sucrose intake. Endocr J 2017;64(Suppl.):S21–S2.10.1507/endocrj.64.S21Suche in Google Scholar PubMed

12. Abtahi S, Mirza A, Howell E, Currie PJ. Ghrelin enhances food intake and carbohydrate oxidation in a nitric oxide-dependent manner. Gen Comp Endocrinol 2017;250:9–14.10.1016/j.ygcen.2017.05.017Suche in Google Scholar PubMed PubMed Central

13. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714–9.10.2337/diabetes.50.8.1714Suche in Google Scholar PubMed

14. Griffin IJ. Catch-up growth: basic mechanisms. Nestle Nutr Inst Workshop Ser 2015;81:87–97.10.1159/000365806Suche in Google Scholar

15. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992.10.1210/jcem.86.12.8111Suche in Google Scholar PubMed

16. Cummings DE. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 2006;89:71–84.10.1016/j.physbeh.2006.05.022Suche in Google Scholar PubMed

17. Akarsu S, Ustundag B, Gurgoze MK, Sen Y, Aygun AD. Plasma ghrelin levels in various stages of development of iron deficiency anemia. J Pediatr Hematol Oncol 2007;29:384–7.10.1097/MPH.0b013e3180645170Suche in Google Scholar PubMed

18. Schmid DA, Held K, Ising M, Uhr M, Weikel JC, et al. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 2005;30:1187–92.10.1038/sj.npp.1300670Suche in Google Scholar PubMed

19. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, et al. Ghrelin strongly stimulates growth hormone (GH) release in humans. J Clin Endocrinol Metab 2000;85:4908–11.10.1210/jcem.85.12.7167Suche in Google Scholar PubMed

20. Stawerska R, Szałapska M, Hilczer M, Lewiński A. Ghrelin, insulin-like growth factor I and adipocytokines concentrations in born small for gestational age prepubertal children after the catch-up growth. J Pediatr Endocrinol Metab 2016;29:939–45.10.1515/jpem-2015-0463Suche in Google Scholar PubMed

21. Keim NL, Stern JS, Havel PJ. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr 1998;68:794–801.10.1093/ajcn/68.4.794Suche in Google Scholar PubMed

22. Yamamoto K, Kuragano T, Kimura T, Nanami M, Hasuike Y, et al. Interplay of adipocyte and hepatocyte: Leptin upregulates hepcidin. Biochem Biophys Res Commun 2018;495:1548–54.10.1016/j.bbrc.2017.11.103Suche in Google Scholar PubMed

23. Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007;137:2366–70.10.1093/jn/137.11.2366Suche in Google Scholar PubMed

24. Dogan A, Alioglu B, Dindar N, Dallar Y. Increased serum hepcidin and ghrelin levels in children treated for iron deficiency anemia. J Clin Lab Anal 2013;27:81–5.10.1002/jcla.21566Suche in Google Scholar PubMed PubMed Central

25. Luo QQ, Zhou YF, Chen MY, Liu L, Ma J, et al. Fasting up-regulates ferroportin 1 expression via a Ghrelin/GHSR/MAPK signaling pathway. J Cell Physiol 2018;233:30–7.10.1002/jcp.25931Suche in Google Scholar PubMed

Received: 2018-08-08
Accepted: 2019-01-01
Published Online: 2019-02-23
Published in Print: 2019-03-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Original Articles
  3. Improved adherence and growth outcomes with jet-delivered growth hormone
  4. Validation of the Greek version of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire
  5. Growth hormone deficiency in children with antenatal Bartter syndrome
  6. Physical growth and development characteristics of children with Williams syndrome aged 0–24 months in Zhejiang Province
  7. Adiposity and adipocytokines: the moderator role of cardiorespiratory fitness and pubertal stage in girls
  8. Serum omentin-1 levels in obese children
  9. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing
  10. Typical characteristics of children with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency: a single-centre experience and review of the literature
  11. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients
  12. The effect of therapy on plasma ghrelin and leptin levels, and appetite in children with iron deficiency anemia
  13. The effect of PKU diet on the maternal quality of life and social discrimination in relation to their educational status and place of living
  14. Evaluating the four most important salivary sex steroids during male puberty: testosterone best characterizes pubertal development
  15. Case Reports
  16. Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing whole exome sequencing
  17. A rare case of congenital hyperinsulinism (CHI) due to dual genetic aetiology involving HNF4A and ABCC8
  18. Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature
Heruntergeladen am 7.2.2026 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0352/html
Button zum nach oben scrollen